NEW YORK (GenomeWeb News) – Cellular analysis toolmaker Fluxion Biosciences said yesterday that it has hired Bucher Biotec to sell and distribute its research tools to drug developers in Switzerland.
 
Under the exclusive agreement, Basel-based Bucher will distribute Fluxion’s BioFlux cell imaging analysis tools.
 
The BioFlux 200 is used in cell adhesion and microbial biofilm studies and allows researchers to study live cells and biofilms under controlled conditions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.